Supernus Pharmaceuticals (SUPN) Stock Price, Quote, News & History

Comments

Supernus Pharmaceuticals Inc (SUPN) Stock Price, Quote, News & History

SUPNNASDAQ

Trade with Public

$51.69

2.344.74%

At close: Mar 31, 5:00 PM EST

$51.69

N/A

After Hours: 4:00 PM EST

OverviewNews Earnings Options Guidance Analyst Ratings Insider Trades Short Interest Government Trades Stock Report

Key Statistics

Open

$49.81

Close

$51.69

Volume / Avg.

396.20K / 732.30K

Day Range

$49.65 - $51.94

52 Wk Range

29.16 - 59.68

Market Cap

$2.89B

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

53

Short Interest

11.36%

Days to Cover

6.51

Recent Supernus Pharmaceuticals Inc News

Pharma ETFs In A Tariff Storm: How Investors Can Hedge Risk

The U.S. pharmaceutical industry is at the center of a policy maelstrom.

Chandrima Sanyal

This Novartis Analyst Is No Longer Bullish; Here Are Top Downgrades For Wednesday

Avi Kapoor

Domino's Pizza To $510? Here Are 10 Top Analyst Forecasts For Wednesday

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

47.33M

Investing Cash Flow (TTM)

4.11M

Financing Cash Flow (TTM)

9.13M

Free Cash Flow (TTM)

45.99M

Capital Expenditure (TTM)

-1.34M

Net Change in Cash (TTM)

60.57M

Analyst Trends and Forecast

3

Oct 25

0

Dec 25

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.0

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$2.58B

PE Ratio (TTM)

-

PE Ratio (FWD)

-

PEG Ratio (TTM)

-

PS Ratio (TTM)

3.88

PB Ratio (TTM)

2.68

Earnings Yield % (TTM)

-1.38%

Earnings Yield % (FWD)

-

EV / EBITDA (TTM)

60.56

Price / EBITDA (TTM)

65.54

Price / Free Cash Flow (TTM)

60.61

Book Value / Share

$18.44

Company Debt

Total Debt

-

LT Debt

-

LT Debt Issuance (TTM)

$0

LT Debt Repayment (TTM)

$0

Total Cash

$128.45M

Debt to Equity

0.04

Issuance of Debt (TTM)

$0

Repayment of Debt (TTM)

$0

Key Statistics

Open

$49.81

Close

$51.69

Volume / Avg.

396.20K / 732.30K

Day Range

$49.65 - $51.94

52 Wk Range

29.16 - 59.68

Market Cap

$2.89B

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

53

Short Interest

11.36%

Days to Cover

6.51

About

Sector

Health Care

Industry

Pharmaceuticals

Supernus Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in developing and commercializing products for the treatment of central nervous system diseases, including neurological and psychiatric disorders. Its diverse ...

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

Q

How do I buy Supernus Pharmaceuticals (SUPN) stock?

A

You can purchase shares of Supernus Pharmaceuticals (NASDAQ:SUPN) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Supernus Pharmaceuticals (SUPN) competitors?

A

Other companies in Supernus Pharmaceuticals’s space includes: Tarsus Pharmaceuticals Inc (NASDAQ:TARS), Phibro Animal Health Corp (NASDAQ:PAHC), Terns Pharmaceuticals Inc (NASDAQ:TERN), ANI Pharmaceuticals Inc (NASDAQ:ANIP) and Alumis Inc (NASDAQ:ALMS).

Q

What is the forecast, or price target, for Supernus Pharmaceuticals (SUPN) stock?

A

Supernus Pharmaceuticals has a consensus price target of $61.60.

Q

What is the current price for Supernus Pharmaceuticals (SUPN)?

A

The stock price for Supernus Pharmaceuticals (NASDAQ: SUPN) is $51.69 last updated March 31, 2026 at 4:00 PM EDT.

Q

Does Supernus Pharmaceuticals (SUPN) pay a dividend?

A

There are no upcoming dividends for Supernus Pharmaceuticals.

Q

When is Supernus Pharmaceuticals (NASDAQ:SUPN) reporting earnings?

A

Supernus Pharmaceuticals does not have any upcoming earnings scheduled.

Q

Is Supernus Pharmaceuticals (SUPN) going to split?

A

There is no upcoming split for Supernus Pharmaceuticals.

Q

What sector and industry does Supernus Pharmaceuticals (SUPN) operate in?

A

Supernus Pharmaceuticals is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.

People Also Watch

Tarsus Pharmaceuticals Inc

NASDAQ:TARS

$70.15

%

Phibro Animal Health Corp

NASDAQ:PAHC

$55.31

%

Terns Pharmaceuticals Inc

NASDAQ:TERN

$52.67

-0.09%

ANI Pharmaceuticals Inc

Ocular Therapeutix Inc

Ligand Pharmaceuticals Inc

NASDAQ:LGND

$199.65

%

Key Statistics

Open

$49.81

Close

$51.69

Volume / Avg.

396.20K / 732.30K

Day Range

$49.65 - $51.94

52 Wk Range

29.16 - 59.68

Market Cap

$2.89B

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

53

Short Interest

11.36%

Days to Cover

6.51

Recent Supernus Pharmaceuticals Inc News

Pharma ETFs In A Tariff Storm: How Investors Can Hedge Risk

The U.S. pharmaceutical industry is at the center of a policy maelstrom.

Chandrima Sanyal

This Novartis Analyst Is No Longer Bullish; Here Are Top Downgrades For Wednesday

Avi Kapoor

Domino's Pizza To $510? Here Are 10 Top Analyst Forecasts For Wednesday

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

47.33M

Investing Cash Flow (TTM)

4.11M

Financing Cash Flow (TTM)

9.13M

Free Cash Flow (TTM)

45.99M

Capital Expenditure (TTM)

-1.34M

Net Change in Cash (TTM)

60.57M

Analyst Trends and Forecast

3

Oct 25

0

Dec 25

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.0

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$2.58B

PE Ratio (TTM)

-

PE Ratio (FWD)

-

PEG Ratio (TTM)

-

PS Ratio (TTM)

3.88

PB Ratio (TTM)

2.68

Earnings Yield % (TTM)

-1.38%

Earnings Yield % (FWD)

-

EV / EBITDA (TTM)

60.56

Price / EBITDA (TTM)

65.54

Price / Free Cash Flow (TTM)

60.61

Book Value / Share

$18.44

Company Debt

Total Debt

-

LT Debt

-

LT Debt Issuance (TTM)

$0

LT Debt Repayment (TTM)

$0

Total Cash

$128.45M

Debt to Equity

0.04

Issuance of Debt (TTM)

$0

Repayment of Debt (TTM)

$0

Key Statistics

Open

$49.81

Close

$51.69

Volume / Avg.

396.20K / 732.30K

Day Range

$49.65 - $51.94

52 Wk Range

29.16 - 59.68

Market Cap

$2.89B

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

53

Short Interest

11.36%

Days to Cover

6.51

About

Sector

Health Care

Industry

Pharmaceuticals

Supernus Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in developing and commercializing products for the treatment of central nervous system diseases, including neurological and psychiatric disorders. Its diverse ...

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry